![Michael Triplett](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Michael Triplett was the founder of Myonexus Therapeutics, Inc., founded in 2017, where the title held was President, Chief Executive Officer & Director from 2017 to 2019.
Dr. Triplett is the founder of Neucore Bio, Inc., founded in 2022, holding the title of Chairman since 2022.
Dr. Triplett is also the founder of Armatus Bio LLC,Clarametyx Biosciences, Inc...
Dr. Triplett currently holds the position of Director at Andelyn Biosciences, Inc. Dr. Triplett currently holds the position of Trustee at BioOhio.
Cargos activos de Michael Triplett
| Empresas | Cargo | Inicio |
|---|---|---|
BioOhio
 BioOhio Miscellaneous Commercial ServicesCommercial Services Engages in supporting bioscience industry | Director/Miembro de la Junta | - |
Armatus Bio LLC
 Armatus Bio LLC BiotechnologyHealth Technology Operates as a biotechnology company which develops vectorized microRNA therapeutics | Fundador | - |
Andelyn Biosciences
 Andelyn Biosciences BiotechnologyHealth Technology Operates as a cell and gene therapy development and contract manufacturing organization | Director/Miembro de la Junta | - |
NEUCORE BIO, INC.
 NEUCORE BIO, INC. BiotechnologyHealth Technology Operates as a biotechnology company that develops genetic medicine technologies using engineered exosomes and extracellular vesicles | Fundador | 01/02/2022 |
Clarametyx Biosciences, Inc.
 Clarametyx Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops immune enabling biological therapies to counter persistent infections associated with biofilms | Fundador | - |
Antiguos cargos conocidos de Michael Triplett.
| Empresas | Cargo | Fin |
|---|---|---|
Myonexus Therapeutics, Inc.
 Myonexus Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for limb-girdle muscular dystrophies | Fundador | 01/04/2019 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
33
Relaciones de 1er grado
6
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
BioOhio
BioOhio Miscellaneous Commercial ServicesCommercial Services Engages in supporting bioscience industry | Commercial Services |
Myonexus Therapeutics, Inc.
Myonexus Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for limb-girdle muscular dystrophies | Health Technology |
Clarametyx Biosciences, Inc.
Clarametyx Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops immune enabling biological therapies to counter persistent infections associated with biofilms | Health Technology |
Andelyn Biosciences
Andelyn Biosciences BiotechnologyHealth Technology Operates as a cell and gene therapy development and contract manufacturing organization | Health Technology |
Armatus Bio LLC
Armatus Bio LLC BiotechnologyHealth Technology Operates as a biotechnology company which develops vectorized microRNA therapeutics | Health Technology |
NEUCORE BIO, INC.
NEUCORE BIO, INC. BiotechnologyHealth Technology Operates as a biotechnology company that develops genetic medicine technologies using engineered exosomes and extracellular vesicles | Health Technology |
- Bolsa de valores
- Insiders
- Michael Triplett
